Pletal Cilostazol

This page contains recent news articles, when available, and an overview of Pletal Cilostazol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

SCHWARZ PHARMA Announces Agreement With OTSUKA For Jointly …  -  Dec 14, 2006
SCHWARZ PHARMA today announced that SCHWARZ PHARMA Deutschland GmbH has signed an agreement with Otsuka Pharma- ceutical Europe Ltd., UK on the joint ... Medical News Today - Medical News Today (press release)

Eon Labs.  -  Jan 17, 2005
Eon Labs. Eon Labs received final approval from the Food and Drug Administration and began shipment of its cilostazol 100 mg tablets, the generic equivalent ... $9.94 - Drug Store News - Alacra Store

Ask the Pharmacist: Can the medicines you take cause problems during ...  -  Oct 4, 2006
By Brad Gentry, PharmD Candidate. Sometimes the answer to this question is yes. Many common medicines have the potential to lead to problems during surgery. ... Medical Leader

Treat peripheral artery disease  -  Sep 15, 2005
For the best results, surgery or angioplasty should be combined with exercise, drug therapy and healthful lifestyle changes. This trio can prevent symptoms ... Pay-Per-View - Sun-News - Factiva, from Dow Jones

Pace: agency rebounds after a tough year to post 20% revenue gains in...  -  Jul 1, 2008
Pace: agency rebounds after a tough year to post 20% revenue gains in 2007.(THE TOP 60) ... find Medical Marketing & Media articles. Pay-Per-View - Medical Marketing & Media - HighBeam Research

Research and Markets: Acalas (Prandipine) - For Hypertension, Angina ...  -  Dec 19, 2006
Pletal (cilostazol) - launched January 1999 for the intermittent claudication associated with peripheral arterial disease. ... $4.95 - Business Wire - ECNext

Opening up treatment for peripheral artery disease.  -  Jul 1, 2005
Lessons from the heart may translate to better treatment for blocked arteries in the legs and elsewhere. The heart isn't the only place in the body where ... $4.95 - Harvard Heart Letter - ECNext

Ronden.se - vårdtidning - jobbrekrytering - karriärtips för vårdperson...  -  Feb 28, 2008
Fönstertittarsjuka är en folksjukdom som varje år handikappar tusentals äldre i form av kraftiga smärtor i benen som starkt begränsar gångförmågan. ... Ronden

Euronext - Van genoteerde ondernemingen > Persberichten  -  Jun 10, 2008
Otsuka et UCB ont convenu d'assurer ensemble la promotion de Keppra®, l'antiépileptique d'UCB, et de Cimzia®, son médicament anti-TNF alpha, au Japon, ... euronext.com

Euronext - Van genoteerde ondernemingen > Persberichten  -  Jun 10, 2008
Otsuka en UCB hebben een overeenstemming bereikt over de gezamenlijke promotie van het anti-epileptische middel Keppra® en het anti-TNF-alfa-middel Cimzia® ... euronext.com

'아빌리파�?�' �?�존�?� 낮춰  -  Jun 12, 2006
...�?�본 오츠카제약�?� 향후 성장�?� 기대�?�는 신약�?� 내세워 유럽�?서 사업�?� 강화한다. 오츠카는 현재 최종 임�?단계�? 있는 심질환 치료제 '톨밥탄'(tolvaptan)과 위장염 ... 디지틀보사

'케프�?�' '심지아' 日서 공�?�개발·�?매  -  Jun 11, 2008
...�?�본 오츠카제약(Otsuka)�?� 벨기�? UCB로부터 간질치료제 '케프�?�'(Keppra, levetiracetam) 와 �?�론병 치료제 '심지아'(Cimzia, certolizumab pegol)를 �?국�?서 공�?� ... 디지틀보사

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.